Indiana SB0157 requires health plans to disclose the national average drug acquisition cost for generic drugs to plan sponsors and covered.

Indiana SB0157 amends the Indiana Code to mandate that health plans provide the national average drug acquisition cost for generic drugs to both the plan sponsor and the covered individual at the point of sale. This disclosure requirement applies to generic drugs covered under a health plan after December 31, 2025, with further amendments applying after December 31, 2026. The bill defines "covered individual" as someone entitled to coverage under a health plan.

Indiana SB0157 requires health plans to disclose the national average drug acquisition cost for generic drugs to plan sponsors and covered.

Indiana SB0157 amends the Indiana Code to mandate that health plans provide the national average drug acquisition cost for generic drugs to both the plan sponsor and the covered individual at the point of sale. This disclosure requirement applies to generic drugs covered under a health plan after December 31, 2025, with further amendments applying after December 31, 2026. The bill defines "covered individual" as someone entitled to coverage under a health plan.